Incorporation of Fenofibrate Nanoparticles Prepared by Melt Emulsification into Polymeric Films

Journal of Pharmaceutical Innovation

Volumn 11, Issue 1, 2016, Pages 53-63

  Bhakay, Anagha ^a   Vizzotti, Emanuel ^a   Li, Meng ^a   Davé, Rajesh ^a   Bilgili, Ecevit ^a  

^a NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Bioavailability enhancement; Drug nanoparticles; Melt emulsification; Physical stability; Polymeric films; Suspensions

Indexed keywords

FENOFIBRATE; GLYCEROL; HYDROXYPROPYLMETHYLCELLULOSE; NANOPARTICLE; POLOXAMER; WATER OIL CREAM;

ARTICLE; CONTROLLED STUDY; COOLING; DRUG SOLUBILITY; DRUG STABILITY; EMULSION; MELT EMULSIFICATION; MELTING POINT; POLYMERIZATION; PRIORITY JOURNAL; SUSPENSION; ULTRASOUND; X RAY DIFFRACTION;

EID: 84958897688     PISSN: 18725120     EISSN: 19398042     Source Type: Journal    
DOI: 10.1007/s12247-015-9237-2     Document Type: Article

References (38)

1. Amidon G, Lennernäs H, Shah V, Crison J. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vitro bioavailability. Pharm Res. 1995;12:413–20.
2. Bruno J, Doty B, Gustow E, Illig K, Rajagopalan N, Sarpotdar P. Method of grinding pharmaceutical substances. US Patent. 1996;5(518):187.
3. Merisko-Liversidge E, Liversidge G, Cooper E. Nanosizing: a formulation approach for poorly water-soluble compounds. Eur J Pharm Sci. 2003;18:113–20.
4. Bhakay A, Merwade M, Bilgili E, Davé R. Novel aspects of wet milling for the production of microsuspensions and nanosuspensions of poorly water-soluble drugs. Drug Dev Ind Pharm. 2011;37:963–76.
5. Noyes A, Whitney W. The rate of solution of solid substances in their own solutions. J Am Chem Soc. 1897;19:930–4.
6. Zhang J, Shen Z, Zhong J, Hu T, Chen J, Ma Z, et al. Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants. Int J Pharm. 2006;323:153–60.
7. Shen S, Ng W, Chia L, Dong Y, Tan R. Stabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties. J Pharm Sci. 2010;99:1997–2007.
8. Jansook P, Kurkov S, Loftsson T. Cyclodextrins as solubilizers: formation of complex aggregates. J Pharm Sci. 2010;99:719–29.
9. Muller M, Peters K. Nanosuspensions for the formulation of poorly soluble drugs: preparation by a size reduction technique. Int J Pharm. 1998;160:229–37.
10. Bilgili E, Afolabi A. A combined microhydrodynamics–polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling. Int J Pharm. 2012;439:193–206.
11. Knieke C, Azad M, Dave R, Bilgili E. A study of the physical stability of wet media-milled fenofibrate suspensions using dynamic equilibrium curves. Chem Eng Res Des. 2013;91:1245–58.
12. Li M, Yaragudi N, Afolabi A, Dave R, Bilgili E. Sub-100 nm drug particle suspensions prepared via wet milling with low bead contamination through novel process intensification. Chem Eng Sci. 2015;130:207–20.
13. Mehnert W, Mader K. Solid lipid nanoparticles production, characterization, and applications. Adv Drug Deliv Rev. 2001;47:165–96.
14. Li X, Gu L, Xu Y, Wang Y. Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats. Drug Dev Ind Pharm. 2009;35:827–33.
15. Kocbek P, Baumgartner S, Kristl J. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int J Pharm. 2006;312:179–86.
16. Knieke C, Rawtani A, Davé R. Concentrated fenofibrate nanoparticle suspensions from melt emulsification for enhanced drug dissolution. Chem Eng Technol. 2014;37:157–67.
17. Köhler K, Henselb A, Krautb M, Schuchmanna H. Melt emulsification—Is there a chance to produce particles without additives? Particuology. 2011;9:506–9.
18. Huang Q, Wang J, Zhang Z, Shen Z, Chen J, Yun J. Preparation of ultrafine fenofibrate powder by solidification process from emulsion. Int J Pharm. 2009;368:160–4.
19. Verma S, Kumar S, Gokhale R, Burgess DJ. Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. Int J Pharm. 2011;406:145–52.
20. Ghosh I, Bose S, Vippagunta R, Harmon F. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. Int J Pharm. 2011;409:260–68.
21. Bilgili E, Li M, Afolabi A. Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions? Pharm Dev and Technol. 2015. doi:10.3109/10837450.2015.1022788.
22. Lee J. Drug nano- and microparticles processed into solid dosage forms: physical properties. J Pharm Sci. 2003;92:2057–68.
23. Van Eerdenbrugh B, Froyen L, Humbeeck J, Martens J, Augustijns P, Mooter G. Drying of crystalline drug nanosuspensions—the importance of surface hydrophobicity on dissolution behavior upon redispersion. Eur J Pharm Sci. 2008;35:127–35.
24. Bhakay A, Bilgili E, Dave R. Recovery of BCS Class II drugs during aqueous redispersion of core–shell type nanocomposite particles produced via fluidized bed coating. Powder Technol. 2013;236:221–34.
25. Abdelwahed W, Degobert G, Fessi H. Investigation of nanocapsules stabilization by amorphous excipients during freeze drying and storage. Eur J Pharm Biopharm. 2006;63:87–94.
26. Sievens-Figueroa L, Bhakay A, Jerez-Rozo J, Pandya N, Romañach R, Michniak-Kohn B, et al. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications. Int J Pharm. 2012;423:496–508.
27. Beck C, Sievens-Figueroa L, Gärtner K, Jerez-Rozo JI, Romañach RJ, Bilgili E, et al. Effects of stabilizers on particle redispersion and dissolution from polymer strip films containing liquid antisolvent precipitated griseofulvin particles. Powder Technol. 2013;236:37–51.
28. Krull S, Susarla R, Afolabi A, Li M, Ying Y, Iqbal Z, et al. Polymer strip films as a robust, surfactant-free platform for delivery of BCS Class II drug nanoparticles. Int J Pharm. 2015;489:45–57.
29. Susarla R, Figueroa L, Bhakay A, Shen Y, Jerez-Rozo J, Engen W, et al. Fast drying of biocompatible polymer films loaded with poorly water-soluble drug nanoparticles via low temperature forced convection. Int J Pharm. 2013;455:93–103.
30. Jamzad S, Fassihi R. Role of surfactant and pH on dissolution profiles of fenofibrate and glipizide—a technical note. AAPS Pharm Sci Tech. 2006;7:E1–6.
31. Figueroa L, Pandya N, Bhakay A, Kevyan G, Michniak-Kohn B, Bilgili E, et al. Using USP I and USP IV for discriminating dissolution rates of nano- and microparticle-loaded pharmaceutical strip-films. AAPS PharmSciTech. 2012;13:1473–82.
32. Baird J, Eerdenbrugh B, Taylor L. A classification system to assess the crystallization tendency of organic molecules from undercooled melts. J Pharm Sci. 2010;99:3787–806.
33. 2. Powder Technol. 2009;196:36–49.
34. Ding P, Pacek A. De-aggregation of goethite nanoparticles using ultrasonic communication device. Powder Technol. 2008;187:1–10.
35. Kusters K, Pratsinis S, Thoma S, Smith D. Ultrasonic fragmentation of agglomerate powders. Chem Eng Sci. 1993;48:4119–27.
36. Bhakay A, Azad M, Bilgili E, Dave R. Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs. Int J Pharm. 2014;461:367–79.
37. Heck J, Deleer M, Fanara D, Vranckx H, Amighi K. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm. 2005;299:167–77.
38. Venkatesh G, Barnett M, Owusu-Fordjour C, Galop M. Detection of low levels of the amorphous step in crystalline pharmaceutical materials by thermally stimulated current spectrometry. Pharm Res. 2001;18:98–103.